Opioids for osteoarthritis? Weighing benefits and risks: A Cochrane Musculoskeletal Group review

Journal of Family Practice

Volumn 60, Issue 4, 2011, Pages 206-212

  Howes, Faline ^a   Buchbinder, Rachelle ^b   Winzenberg, Tania ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DICLOFENAC; DIHYDROCODEINE; HYDROCODONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PENTAZOCINE; PLACEBO; TRAMADOL;

ADD ON THERAPY; CLINICAL PRACTICE; CONSTIPATION; DEATH; DISABILITY; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; DRUG INDICATION; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT; HEADACHE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; RISK BENEFIT ANALYSIS; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VERTIGO; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES INDEX; RISK FACTOR;

ANALGESICS, OPIOID; HUMANS; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TRAMADOL;

EID: 79959622984     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26-35.
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009;15(suppl):S230-S235.
3. Altman RD, Hochberg MC, Moskowitz RW, et al. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 2000;43:1905-1915.
4. Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am J Med. 1996;101(suppl 1A):47S-53S. (Pubitemid 26269076)
5. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613-2620.
6. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS data brief, no 22. Hyattsville, MD: National Center for Health Statistics; 2009.
7. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain. 2004;109:207-209. (Pubitemid 38638695)
8. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137-167.
9. Pletcher MJ, Kertesz SG, Kohn MA, et al. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70-78.
10. Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2006;(3):CD005522.
11. Nuesch E, Rutjes AW, Husni E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2009;(4):CD003115.
12. Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000;27:2635-2641.
13. Bianchi M, Broggini M, Balzarini P, et al. Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol. Int Immunopharm. 2003;3:1901-1908. (Pubitemid 37421273)
14. Wilder-Smith C, Hill L, Spargo K, et al. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain. 2001;91:23-31. (Pubitemid 32274172)
15. Jensen E, Ginsberg F. Tramadol versus dextropropoxyphene in the treatment of osteoarthritis: a short-term double-blind study. Drug Invest. 1994:8:211-218. (Pubitemid 24319459)
16. Bird H, Hill J, Stratford M, et al. A double-blind cross-over study comparing the analgesic efficacy of tramadol with pentazocine in patients with osteoarthritis. J Drug Dev Clin Pract. 1995;7:181-188.
17. Pavelka K, Peliskova Z, Stehlikova H, et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Invest. 1998;16:421-429. (Pubitemid 29012064)
18. Townheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;(1):CD004257.
19. Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlledrelease tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial. Pain Res Manag. 2008;13:103-110. (Pubitemid 351865292)
20. Gana TJ, Pascual ML, Fleming RR, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin. 2006;22:1391-1401. (Pubitemid 44085591)
21. Delemos BP, Xiang J, Benson C, et al. Tramadol hydrochloride extended- release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther. 2010 Mar 3 [Epub ahead of print].
22. Burch F, Fishman R, Messina N, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage. 2007;34:328-338. (Pubitemid 47371077)